AKEBIACARES Trademark

Trademark Overview


On Thursday, April 4, 2019, a trademark application was filed for AKEBIACARES with the United States Patent and Trademark Office. The USPTO has given the AKEBIACARES trademark a serial number of 88371599. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, July 8, 2025. This trademark is owned by Akebia Therapeutics, Inc.. The AKEBIACARES trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing patients who have been prescribed a course of therapy that involves prescription pharmaceuticals with financial information on medical and pharmacy insurance coverage, patient reimbursement options and financial support for that therapy

Providing patients who have been prescribed a course of therapy that involves prescription pharmaceuticals with business information on medical and pharmacy insurance coverage, patient reimbursement options and financial support for that therapy

[ Charitable services, namely, patient assistance program to provide drugs free of charge to low-income patients without prescription drug coverage; ] providing patients who have been prescribed a course of therapy that involves prescription pharmaceuticals with medical informational, advice, and consultation on those pharmaceuticals
akebiacares

General Information


Serial Number88371599
Word MarkAKEBIACARES
Filing DateThursday, April 4, 2019
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, July 8, 2025
Registration Number6004026
Registration DateTuesday, March 3, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2019

Trademark Statements


Pseudo MarkAKEBIA CARES
Goods and ServicesProviding patients who have been prescribed a course of therapy that involves prescription pharmaceuticals with financial information on medical and pharmacy insurance coverage, patient reimbursement options and financial support for that therapy
Goods and ServicesProviding patients who have been prescribed a course of therapy that involves prescription pharmaceuticals with business information on medical and pharmacy insurance coverage, patient reimbursement options and financial support for that therapy
Goods and Services[ Charitable services, namely, patient assistance program to provide drugs free of charge to low-income patients without prescription drug coverage; ] providing patients who have been prescribed a course of therapy that involves prescription pharmaceuticals with medical informational, advice, and consultation on those pharmaceuticals

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, July 19, 2019
Primary Code035
First Use Anywhere DateMonday, June 3, 2019
First Use In Commerce DateMonday, June 3, 2019

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, April 22, 2019
Primary Code036
First Use Anywhere DateMonday, June 3, 2019
First Use In Commerce DateMonday, June 3, 2019

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 19, 2019
Primary Code044
First Use Anywhere DateMonday, June 3, 2019
First Use In Commerce DateMonday, June 3, 2019

Trademark Owner History


Party NameAkebia Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameAkebia Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameAkebia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Thursday, June 27, 2019PRIORITY ACTION WRITTEN
Monday, April 8, 2019NEW APPLICATION ENTERED
Monday, April 22, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 14, 2019ASSIGNED TO EXAMINER
Thursday, June 27, 2019PRIORITY ACTION E-MAILED
Thursday, June 27, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, July 18, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 19, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 2, 2019ASSIGNED TO LIE
Wednesday, August 21, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 10, 2019PUBLISHED FOR OPPOSITION
Tuesday, September 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, January 3, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, November 5, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 16, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, January 18, 2020STATEMENT OF USE PROCESSING COMPLETE
Friday, January 3, 2020USE AMENDMENT FILED
Friday, January 24, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, January 25, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 3, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, April 18, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 18, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 3, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, March 10, 2025TEAS SECTION 8 & 15 RECEIVED
Tuesday, July 8, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 8, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, July 8, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED